EAACI Congress 2025
BackTPS63 - Anaphylaxis 04
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
D3.270
A novel workflow for cell metabolomics: impact of anaphylaxis in a human endothelial system
D3.276
Acalabrutinib as premedication in platinum agents desensitization protocols: a case series supporting its role in enhancing tolerance with a repeatible efficacity
D3.275
Anaphylaxis caused by polyhexanide
D3.273
Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria
D3.265
Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report
D3.268
Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production
D3.269
Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings
D3.277
Features of severe anaphylaxis in children, data from the Moscow Pediatric Register
D3.272
Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients
D3.274
Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria
